China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS)
CNY 18.86
(0.27%)
CNY 18.86
(0.27%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.21 Billion CNY | 6.22% |
| 2022 | 1.99 Billion CNY | 22.14% |
| 2021 | 1.58 Billion CNY | -2.74% |
| 2020 | 1.59 Billion CNY | -0.95% |
| 2019 | 1.63 Billion CNY | 8.85% |
| 2018 | 1.54 Billion CNY | 8.5% |
| 2017 | 1.39 Billion CNY | 13.42% |
| 2016 | 1.22 Billion CNY | 13.01% |
| 2015 | 1.08 Billion CNY | 22.28% |
| 2014 | 1.08 Billion CNY | -34.1% |
| 2013 | 1.36 Billion CNY | 33.61% |
| 2012 | 983.65 Million CNY | 12.36% |
| 2011 | 902.96 Million CNY | 12.73% |
| 2010 | 787.33 Million CNY | 13.1% |
| 2009 | 695.92 Million CNY | 17.63% |
| 2008 | 610.36 Million CNY | 0.11% |
| 2007 | 562.6 Million CNY | 61.83% |
| 2006 | 370.16 Million CNY | -6.98% |
| 2005 | 408.3 Million CNY | 105.81% |
| 2004 | 198.39 Million CNY | -22.5% |
| 2003 | 255.28 Million CNY | -23.01% |
| 2002 | 332.48 Million CNY | 10.55% |
| 2001 | 292.07 Million CNY | 25.12% |
| 2000 | 213.34 Million CNY | 45.53% |
| 1999 | 164.36 Million CNY | 102.72% |
| 1998 | 81.47 Million CNY | 70.34% |
| 1997 | 47.83 Million CNY | -10.8% |
| 1996 | 53.62 Million CNY | 11.72% |
| 1995 | 47.99 Million CNY | 440.33% |
| 1994 | -14.1 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 743.03 Million CNY | 29.59% |
| 2024 Q1 | 533.41 Million CNY | 57.83% |
| 2024 Q3 | 422.54 Million CNY | -52.44% |
| 2023 Q1 | 476.78 Million CNY | 180.6% |
| 2023 Q2 | 481.18 Million CNY | 0.92% |
| 2023 Q3 | 372.99 Million CNY | -22.48% |
| 2023 Q4 | 339.31 Million CNY | -9.03% |
| 2023 FY | - CNY | 6.22% |
| 2022 Q4 | 169.91 Million CNY | -49.1% |
| 2022 Q1 | 434.56 Million CNY | 490.71% |
| 2022 Q2 | 509.53 Million CNY | 17.25% |
| 2022 Q3 | 333.84 Million CNY | -34.48% |
| 2022 FY | - CNY | 22.14% |
| 2021 FY | - CNY | -2.74% |
| 2021 Q1 | 374 Million CNY | 45.21% |
| 2021 Q2 | 369.17 Million CNY | -1.29% |
| 2021 Q3 | 346.19 Million CNY | -6.22% |
| 2021 Q4 | 73.56 Million CNY | -78.75% |
| 2020 Q4 | 257.56 Million CNY | -31.55% |
| 2020 Q2 | 333.14 Million CNY | -3.38% |
| 2020 Q3 | 376.28 Million CNY | 12.95% |
| 2020 FY | - CNY | -0.95% |
| 2020 Q1 | 344.8 Million CNY | 70.22% |
| 2019 Q1 | 413.63 Million CNY | 147.28% |
| 2019 FY | - CNY | 8.85% |
| 2019 Q2 | 371.28 Million CNY | -10.24% |
| 2019 Q3 | 344.86 Million CNY | -7.12% |
| 2019 Q4 | 202.56 Million CNY | -41.26% |
| 2018 Q4 | 167.27 Million CNY | -46.22% |
| 2018 Q2 | 334.63 Million CNY | -15.43% |
| 2018 Q3 | 311.01 Million CNY | -7.06% |
| 2018 Q1 | 395.67 Million CNY | 155.9% |
| 2018 FY | - CNY | 8.5% |
| 2017 Q1 | 321.72 Million CNY | 62.66% |
| 2017 Q3 | 263.14 Million CNY | -23.87% |
| 2017 Q2 | 345.65 Million CNY | 7.44% |
| 2017 Q4 | 154.61 Million CNY | -41.24% |
| 2017 FY | - CNY | 13.42% |
| 2016 Q1 | 230.89 Million CNY | -31.87% |
| 2016 Q4 | 197.78 Million CNY | -7.33% |
| 2016 FY | - CNY | 13.01% |
| 2016 Q3 | 213.43 Million CNY | -34.87% |
| 2016 Q2 | 327.72 Million CNY | 41.93% |
| 2015 Q3 | 106.91 Million CNY | -47.8% |
| 2015 Q1 | 218.64 Million CNY | 50.2% |
| 2015 Q2 | 204.8 Million CNY | -6.33% |
| 2015 Q4 | 338.92 Million CNY | 217.01% |
| 2015 FY | - CNY | 22.28% |
| 2014 Q3 | 141.43 Million CNY | -29.1% |
| 2014 FY | - CNY | -34.1% |
| 2014 Q2 | 199.48 Million CNY | -0.76% |
| 2014 Q1 | 201.01 Million CNY | -52.09% |
| 2014 Q4 | 145.56 Million CNY | 2.92% |
| 2013 Q1 | 217.22 Million CNY | 11.14% |
| 2013 Q3 | 250.61 Million CNY | 6.86% |
| 2013 FY | - CNY | 33.61% |
| 2013 Q2 | 234.52 Million CNY | 7.96% |
| 2013 Q4 | 419.59 Million CNY | 67.43% |
| 2012 Q3 | 190.33 Million CNY | 3.24% |
| 2012 Q1 | 282.58 Million CNY | 9.59% |
| 2012 Q4 | 195.44 Million CNY | 2.69% |
| 2012 FY | - CNY | 12.36% |
| 2012 Q2 | 184.36 Million CNY | -34.76% |
| 2011 FY | - CNY | 12.73% |
| 2011 Q1 | 223.5 Million CNY | 69.67% |
| 2011 Q4 | 257.86 Million CNY | 76.52% |
| 2011 Q3 | 146.08 Million CNY | -6.17% |
| 2011 Q2 | 155.68 Million CNY | -30.34% |
| 2010 Q2 | 147.52 Million CNY | -31.06% |
| 2010 FY | - CNY | 13.1% |
| 2010 Q4 | 131.72 Million CNY | -19.57% |
| 2010 Q3 | 163.78 Million CNY | 11.02% |
| 2010 Q1 | 213.96 Million CNY | 23.77% |
| 2009 Q2 | 113.52 Million CNY | -31.63% |
| 2009 FY | - CNY | 17.63% |
| 2009 Q4 | 172.87 Million CNY | 27.28% |
| 2009 Q3 | 135.82 Million CNY | 19.64% |
| 2009 Q1 | 166.05 Million CNY | 80.15% |
| 2008 Q1 | 129.4 Million CNY | -21.18% |
| 2008 Q2 | 136.53 Million CNY | 5.51% |
| 2008 Q3 | 130.8 Million CNY | -4.2% |
| 2008 Q4 | 92.17 Million CNY | -29.53% |
| 2008 FY | - CNY | 0.11% |
| 2007 FY | - CNY | 61.83% |
| 2007 Q4 | 164.17 Million CNY | 6.06% |
| 2007 Q3 | 154.78 Million CNY | -9.3% |
| 2007 Q2 | 170.65 Million CNY | 118.31% |
| 2007 Q1 | 78.17 Million CNY | -35.59% |
| 2006 FY | - CNY | -6.98% |
| 2006 Q4 | 121.37 Million CNY | 58.76% |
| 2006 Q3 | 76.45 Million CNY | -25.08% |
| 2006 Q2 | 102.04 Million CNY | 4.34% |
| 2006 Q1 | 97.8 Million CNY | -40.91% |
| 2005 Q2 | 192.11 Million CNY | 104.35% |
| 2005 Q4 | 165.52 Million CNY | 102.96% |
| 2005 FY | - CNY | 105.81% |
| 2005 Q1 | 94.01 Million CNY | 524.88% |
| 2005 Q3 | 81.55 Million CNY | -57.55% |
| 2004 Q1 | 82.68 Million CNY | 663.24% |
| 2004 Q4 | -22.12 Million CNY | -165.75% |
| 2004 Q3 | 33.65 Million CNY | 3.73% |
| 2004 Q2 | 32.44 Million CNY | -60.76% |
| 2004 FY | - CNY | -22.5% |
| 2003 FY | - CNY | -23.01% |
| 2003 Q4 | 10.83 Million CNY | -87.12% |
| 2003 Q1 | 77.05 Million CNY | 39.64% |
| 2003 Q3 | 84.09 Million CNY | -20.15% |
| 2003 Q2 | 105.3 Million CNY | 36.66% |
| 2002 FY | - CNY | 10.55% |
| 2002 Q4 | 55.18 Million CNY | 14.95% |
| 2002 Q3 | 48 Million CNY | -47.58% |
| 2002 Q2 | 91.57 Million CNY | 90.35% |
| 2002 Q1 | 48.1 Million CNY | 0.0% |
| 2001 FY | - CNY | 25.12% |
| 2000 FY | - CNY | 45.53% |
| 1999 FY | - CNY | 102.72% |
| 1998 FY | - CNY | 70.34% |
| 1997 FY | - CNY | -10.8% |
| 1996 FY | - CNY | 11.72% |
| 1995 FY | - CNY | 440.33% |
| 1994 FY | - CNY | 0.0% |